Isaacs JT - Search Results

1

Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587).

Dionne CA, Camoratto AM, Jani JP, Emerson E, Neff N, Vaught JL, Murakata C, Djakiew D, Lamb J, Bova S, George D, Isaacs JT. Dionne CA, et al. Among authors: isaacs jt. Clin Cancer Res. 1998 Aug;4(8):1887-98. Clin Cancer Res. 1998. PMID: 9717816

2

The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers.

Ichikawa T, Lamb JC, Christensson PI, Hartley-Asp B, Isaacs JT. Ichikawa T, et al. Among authors: isaacs jt. Cancer Res. 1992 Jun 1;52(11):3022-8. Cancer Res. 1992. PMID: 1591718

3

Response of rat and human prostatic cancers to the novel 5 alpha-reductase inhibitor, SK&F 105657.

Lamb JC, Levy MA, Johnson RK, Isaacs JT. Lamb JC, et al. Among authors: isaacs jt. Prostate. 1992;21(1):15-34. doi: 10.1002/pros.2990210103. Prostate. 1992. PMID: 1641369

4

Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response.

Lamb JC, English H, Levandoski PL, Rhodes GR, Johnson RK, Isaacs JT. Lamb JC, et al. Among authors: isaacs jt. Endocrinology. 1992 Feb;130(2):685-94. doi: 10.1210/endo.130.2.1733716. Endocrinology. 1992. PMID: 1733716

5

Evaluation of Win 49,596, a novel steroidal androgen receptor antagonist, in animal models of prostate cancer.

Juniewicz PE, Fetrow N, Marinelli J, Wolf M, Young E, Lamb J, Isaacs JT. Juniewicz PE, et al. Among authors: isaacs jt. Prostate. 1991;18(2):105-15. doi: 10.1002/pros.2990180203. Prostate. 1991. PMID: 2006117

6

Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide.

Vukanovic J, Isaacs JT. Vukanovic J, et al. Among authors: isaacs jt. Cancer Res. 1995 Aug 15;55(16):3517-20. Cancer Res. 1995. PMID: 7543015

7

The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin.

Furuya Y, Lundmo P, Short AD, Gill DL, Isaacs JT. Furuya Y, et al. Among authors: isaacs jt. Cancer Res. 1994 Dec 1;54(23):6167-75. Cancer Res. 1994. PMID: 7954463

8

CEP-751 inhibits TRK receptor tyrosine kinase activity in vitro exhibits anti-tumor activity.

Camoratto AM, Jani JP, Angeles TS, Maroney AC, Sanders CY, Murakata C, Neff NT, Vaught JL, Isaacs JT, Dionne CA. Camoratto AM, et al. Among authors: isaacs jt. Int J Cancer. 1997 Aug 7;72(4):673-9. doi: 10.1002/(sici)1097-0215(19970807)72:4<673::aid-ijc20>3.0.co;2-b. Int J Cancer. 1997. PMID: 9259409

9

Mutational analysis of the TrkA gene in prostate cancer.

George DJ, Suzuki H, Bova GS, Isaacs JT. George DJ, et al. Among authors: isaacs jt. Prostate. 1998 Aug 1;36(3):172-80. doi: 10.1002/(sici)1097-0045(19980801)36:3<172::aid-pros5>3.0.co;2-j. Prostate. 1998. PMID: 9687989

10

Implication of cell kinetic changes during the progression of human prostatic cancer.

Berges RR, Vukanovic J, Epstein JI, CarMichel M, Cisek L, Johnson DE, Veltri RW, Walsh PC, Isaacs JT. Berges RR, et al. Among authors: isaacs jt. Clin Cancer Res. 1995 May;1(5):473-80. Clin Cancer Res. 1995. PMID: 9816006 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters